This company is no longer active
Diffusion Pharmaceuticals Past Earnings Performance
Past criteria checks 0/6
Key information
-19.2%
Earnings growth rate
48.6%
EPS growth rate
Biotechs Industry Growth | -14.6% |
Revenue growth rate | n/a |
Return on equity | -62.3% |
Net Margin | n/a |
Last Earnings Update | 30 Sep 2022 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses BreakdownBeta
How Diffusion Pharmaceuticals makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 22 | 0 | -15 | 8 | 7 |
30 Jun 22 | 0 | -24 | 8 | 8 |
31 Mar 22 | 0 | -24 | 8 | 8 |
31 Dec 21 | 0 | -24 | 7 | 8 |
30 Sep 21 | 0 | -25 | 7 | 10 |
30 Jun 21 | 0 | -17 | 7 | 11 |
31 Mar 21 | 0 | -18 | 7 | 11 |
31 Dec 20 | 0 | -16 | 6 | 9 |
30 Sep 20 | 0 | -16 | 6 | 9 |
30 Jun 20 | 0 | -14 | 5 | 7 |
31 Mar 20 | 0 | -12 | 5 | 6 |
31 Dec 19 | 0 | -12 | 5 | 7 |
30 Sep 19 | 0 | -14 | 5 | 6 |
30 Jun 19 | 0 | -18 | 5 | 6 |
31 Mar 19 | 0 | -18 | 6 | 6 |
31 Dec 18 | 0 | -27 | 6 | 6 |
30 Sep 18 | 0 | -20 | 6 | 6 |
30 Jun 18 | 0 | -10 | 6 | 6 |
31 Mar 18 | 0 | 4 | 6 | 6 |
31 Dec 17 | 0 | -3 | 6 | 5 |
30 Sep 17 | 0 | -7 | 6 | 5 |
30 Jun 17 | 0 | -15 | 8 | 5 |
31 Mar 17 | 0 | -30 | 6 | 5 |
31 Dec 16 | 0 | -18 | 9 | 6 |
30 Sep 16 | 0 | -18 | 9 | 6 |
30 Jun 16 | 0 | -14 | 5 | 6 |
Quality Earnings: DP81 is currently unprofitable.
Growing Profit Margin: DP81 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: DP81 is unprofitable, and losses have increased over the past 5 years at a rate of 19.2% per year.
Accelerating Growth: Unable to compare DP81's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: DP81 is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-15.9%).
Return on Equity
High ROE: DP81 has a negative Return on Equity (-62.32%), as it is currently unprofitable.